Cross Reactions
This graph shows the total number of publications written about "Cross Reactions" by people in the URMC Research Network by year, and whether "Cross Reactions" was a major or minor topic of these publication.
Below are the most recent publications written about "Cross Reactions" by people in Profiles.
-
Scheible K, Zhang G, Baer J, Azadniv M, Lambert K, Pryhuber G, Treanor JJ, Topham DJ. CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses. Vaccine. 2011 Mar 3; 29(11):2159-68.
-
Mace CR, Topham DJ, Mosmann TR, Quataert SA, Treanor JJ, Miller BL. Label-free, arrayed sensing of immune response to influenza antigens. Talanta. 2011 Jan 15; 83(3):1000-5.
-
Guo H, Santiago F, Lambert K, Takimoto T, Topham DJ. T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model. J Virol. 2011 Jan; 85(1):448-55.
-
Ahmad A, Sarfraz A. Screening and partial immunochemical characterization of sulfite oxidase from plant source. Indian J Exp Biol. 2010 Jan; 48(1):83-6.
-
Baer J, Santiago F, Yang H, Wu H, Holden-Wiltse J, Treanor J, Topham DJ. B cell responses to H5 influenza HA in human subjects vaccinated with a drifted variant. Vaccine. 2010 Jan 22; 28(4):907-15.
-
Richards KA, Chaves FA, Sant AJ. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus. J Virol. 2009 Jul; 83(13):6566-77.
-
Davis KL, Gray ES, Moore PL, Decker JM, Salomon A, Montefiori DC, Graham BS, Keefer MC, Pinter A, Morris L, Hahn BH, Shaw GM. High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination. Virology. 2009 May 10; 387(2):414-26.
-
Rodrigo WW, Alcena DC, Kou Z, Kochel TJ, Porter KR, Comach G, Rose RC, Jin X, Schlesinger JJ. Difference between the abilities of human Fcgamma receptor-expressing CV-1 cells to neutralize American and Asian genotypes of dengue virus 2. Clin Vaccine Immunol. 2009 Feb; 16(2):285-7.
-
DePestel DD, Benninger MS, Danziger L, LaPlante KL, May C, Luskin A, Pichichero M, Hadley JA. Cephalosporin use in treatment of patients with penicillin allergies. J Am Pharm Assoc (2003). 2008 Jul-Aug; 48(4):530-40.
-
Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. J Virol. 2007 Dec; 81(23):12816-26.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
|
